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Background and Significance
Type two diabetes mellitus (T2DM) is a chronic
metabolic disorder that has become increasingly
common in the United States and around the world.
Metabolic disorders such as T2DM and obesity are
known to have a chronic low grade inflammatory
tissue environment as well as an increase in
excess lipids. Current research suggests that a
tightly regulated oligoprotein complex known as the
NLRP3 inflammasome is highly activated in T2DM
and obesity. However, it is not well understood the
interplay between excess lipids and inflammation. A
key transcription factor that is known to have both
an inflammatory effect as well as an effect on lipid
metabolism is PPARγ. For this reason, we
attempted to determine if PPARγ had an effect on
the degree of pro-inflammatory cytokine release
such as IL-1β in the presence of excess lipids.
Figure 3. mPPARγKO pMACs selective 
depletes IL-1 levels. Loss of PPARγ from 
activated macrophages led to a selective 
reduction in IL-1 mRNA and protein (A-C).  
Figure 4. Heightened production and 
release of  IFNβ signaling in mPPARγ KO 
cells. RNA sequencing and qPCR revealed an 
increase IFN-regulated genes (A-B), as well as 
IFNβ levels (C-D).
Figure 6. rIFNβ sufficient to reproduce PPARγ
KO phenotype. rIFNβ given to WT cells 
phenocopied mPPARγKO cells. IFNβ levels caused 
a dose dependent decrease in IL-1β and had no 
effect on TNFα.  
Figure 2. mPPARγ KO mouse model.
Hypothesis
We hypothesized loss of PPARγ would be
protective by altering lipid metabolism in
macrophages.
Methods
In an attempt to determine the interplay between
lipid metabolism and inflammation, we created a
myeloid specific PPARγ KO mouse model. WT or
indicated KO peritoneal macrophages (pMACs)
were isolated from mice and adhered to indicated
plates. To activate the inflammasome a lipid
cocktail, namely palmitate, and LPS were given to
active the inflammasome complex in pMACs.
The NLRP3 Inflammasome Activation  
Figure 1. Schematic of lipotoxic inflammasome
activation with and without PPARγ.
Discussion
Myeloid specific loss of PPARγ leads to selective reduction of
IL-1β due to an effect on signal 1 of the inflammasome and
increased IFNβ. Further research should investigate how loss of
PPARγ leads to increased IFNβ. Also it is advantageous to
study how increased IFNβ leads to selective depletion of IL-1
levels.
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Figure 7. Schematic of inflammasome with IFNβ
response..
Figure 5. Neutralization of IFNβ signaling 
normalized IL-1 Levels.  Blockade of IFNβ 
signaling with the IFNAR1 antibody restored IL-1β
levels to WT levels. 
